Why We should Assess Patients' Expectations in Clinical Trials

Elisa Frisaldi, Aziz Shaibani, Fabrizio Benedetti, Elisa Frisaldi, Aziz Shaibani, Fabrizio Benedetti

Abstract

Most of the analgesic clinical trials have failed to succeed over the past years because of the occurrence of large placebo responses. Patients' expectations about the therapeutic benefit represent a major determinant of the placebo response. Therefore, assessing patients' expectations should become the rule in any clinical trial. This would allow us to better interpret therapeutic outcomes when comparing placebo and verum groups.

Keywords: Clinical trial; Expectation; Placebo effect.

References

    1. Benedetti F, Carlino E, Piedimonte A. Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects. Lancet Neurol. 2016;15:736–747. doi: 10.1016/S1474-4422(16)00066-1.
    1. Shaibani A, Frisaldi E, Benedetti F. Placebo response in pain, fatigue, and performance: possible implications for neuromuscular disorders. Muscle Nerve. 2017. doi:10.1002/mus.25635.
    1. Bartfai T, Lees GV. Pharma TARP: a troubled asset relief program for novel, abandoned projects in the pharmaceutical industry. Sci World J. 2011;11:454–457. doi: 10.1100/tsw.2011.61.
    1. Dolgin E. Fluctuating baseline pain implicated in failure of clinical trials. Nat Med. 2010;16:1053.
    1. Katz J, Finnerup NB, Dworkin RH. Clinical trial outcome in neuropathic pain: relationship to study characteristics. Neurology. 2008;70:263–272. doi: 10.1212/01.wnl.0000275528.01263.6c.
    1. Tuttle AH, et al. Increasing placebo responses over time in U.S. clinical trials of neuropathic pain. Pain. 2015;156:2616–2626. doi: 10.1097/j.pain.0000000000000333.
    1. Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression: variable, substantial, and growing. JAMA. 2002;287:1840–1847. doi: 10.1001/jama.287.14.1840.
    1. Dworkin RH, Katz J, Gitlin MJ. Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain. Neurology. 2005;65:S7–S19. doi: 10.1212/WNL.65.12_suppl_4.S7.
    1. Younger J, et al. Development of the Stanford Expectations of Treatment Scale (SETS): a tool for measuring patient outcome expectancy in clinical trials. Clin Trials. 2012;9:767–776. doi: 10.1177/1740774512465064.
    1. Sneed JR, et al. Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. Am J Geriatr Psychiatry. 2008;16:65–73. doi: 10.1097/JGP.0b013e3181256b1d.
    1. Rutherford BR, Sneed JR, Roose SP. Does study design influence outcome? The effects of placebo control and treatment duration in antidepressant trials. Psychother Psychosom. 2009;78:172–181. doi: 10.1159/000209348.
    1. Rutherford BR, et al. Patient expectancy as a mediator of placebo effects in antidepressant clinical trials. Am J Psychiatry. 2017;174:135–142. doi: 10.1176/appi.ajp.2016.16020225.
    1. Bausell RB, et al. Is acupuncture analgesia an expectancy effect? Preliminary evidence based on participants’ perceived assignments in two placebo-controlled trials. Eval Health Prof. 2005;28:9–26. doi: 10.1177/0163278704273081.
    1. Linde K, et al. The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain. 2007;128:264–271. doi: 10.1016/j.pain.2006.12.006.
    1. Benedetti F, Durando J, Vighetti S. Nocebo and placebo modulation of hypobaric hypoxia headache involves the cyclooxygenase-prostaglandins pathway. Pain. 2014;155:921–928. doi: 10.1016/j.pain.2014.01.016.
    1. Rief W, et al. Preoperative optimization of patient expectations improves long-term outcome in heart surgery patients: results of the randomized controlled PSY-HEART trial. BMC Med. 2017;10(15):4. doi: 10.1186/s12916-016-0767-3.
    1. Daniels AM, Sallie R. Headache, lumbar puncture, and expectation. Lancet. 1981;1:1003. doi: 10.1016/S0140-6736(81)91771-2.
    1. Amanzio M, et al. A systematic review of adverse events in placebo groups of anti-migraine clinical trials. Pain. 2009;146:261–269. doi: 10.1016/j.pain.2009.07.010.
    1. Giustini D. Social media and clinical trials recruitment: potential benefits and challenges. J Can Health Libr Assoc. 2012;33:140–145. doi: 10.5596/c12-044.
    1. Allison M. Can Web 2.0 reboot clinical trials? Nat Biotech. 2009;27(895):902.
    1. Coons S. Communication through social media: its potential and pitfalls. Res Prac. 2012;13(44):50.

Source: PubMed

3
Iratkozz fel